AI assistant
Sending…
Panacea Biotec Ltd. — Capital/Financing Update 2019
Apr 9, 2019
62573_rns_2019-04-09_34058ba3-d059-4032-a931-6a0407821a73.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [61 x 5] intentionally omitted <==
==> picture [159 x 17] intentionally omitted <==
| S.No. | Particulars | Description |
|---|---|---|
| I. | Reasons for opting for | In order to resolve the current debt positionofthe |
| OTS | Company. | |
| 2. | Briefsummaryofthe | All consortium lenders have approved the bilateral OTS at |
| OTS | 65%oftheir outstanding debts. |
More from Panacea Biotec Ltd.
Interim / Quarterly Report
2026
May 30
Interim / Quarterly Report
2026
May 30
Interim / Quarterly Report
2026
May 30
Interim / Quarterly Report
2026
May 30
Interim / Quarterly Report
2026
May 30
Board/Management Information
2026
May 29
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 29
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 23